Harvard Bioscience (HBIO) director awarded 16,556 restricted stock units
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Snider William reported acquisition or exercise transactions in this Form 4 filing.
Harvard Bioscience director William Snider received an equity grant in the form of 16,556 restricted stock units of common stock. The award vests in full immediately before the company’s next annual meeting or one year from the grant date, whichever occurs first, providing time-based compensation for board service.
After this grant, Snider holds a total of 48,556 common share equivalents, including the new award, previously purchased common shares from March 16 and March 17, 2026, and 11,000 restricted stock units scheduled to fully vest on December 17, 2026. The filing also notes that the 11,000 restricted stock units were adjusted to reflect a 10-for-1 reverse stock split that took place on March 13, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Snider William
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 16,556 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 48,556 shares (Direct, null)
Footnotes (1)
- Represents an award of 16,556 restricted stock units that vests in full (i) immediately prior to the Company's next annual meeting; or (ii) one year from the date of grant, whichever is earlier. Includes (a) the award described in footnote (1) above, (b) 12,525 shares of common stock purchased on March 16, 2026, (c) 8,475 shares of common stock purchased on March 17, 2026, and (d) 11,000 restricted stock units that fully vest on December 17, 2026. On March 13, 2026, the common stock of Harvard Bioscience, Inc. underwent a reverse stock split in a ratio of 10-for-1. The 11,000 restricted stock units referenced in Footnote 2(d) were previously reported as covering 110,000 restricted stock units. This number has been adjusted to reflect the stock split that occurred on March 13, 2026.
Key Figures
RSUs granted: 16,556 units
Grant price: $0.00 per share
Total holdings after grant: 48,556 shares/units
+3 more
6 metrics
RSUs granted
16,556 units
Restricted stock unit award to director on June 9, 2026
Grant price
$0.00 per share
Compensation grant, not open-market purchase
Total holdings after grant
48,556 shares/units
Common share equivalents following the reported transaction
Previously purchased shares
12,525 + 8,475 shares
Common stock purchases on March 16 and March 17, 2026
Unvested RSUs
11,000 units
Restricted stock units vesting on December 17, 2026
Reverse stock split ratio
10-for-1
Reverse split of common stock on March 13, 2026
Key Terms
restricted stock units, annual meeting, reverse stock split, 10-for-1, +1 more
5 terms
restricted stock units financial
"Represents an award of 16,556 restricted stock units that vests in full..."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
annual meeting financial
"...vests in full (i) immediately prior to the Company's next annual meeting..."
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
reverse stock split financial
"On March 13, 2026, the common stock of Harvard Bioscience, Inc. underwent a reverse stock split in a ratio of 10-for-1."
A reverse stock split is when a company reduces the number of its shares outstanding, making each share more valuable. For example, if you own 100 shares worth $1 each, a 1-for-10 reverse split would turn your 100 shares into 10 shares worth $10 each. Companies often do this to boost their stock price and appear more stable to investors.
10-for-1 financial
"...underwent a reverse stock split in a ratio of 10-for-1."
common stock financial
"Includes (a) the award described in footnote (1) above, (b) 12,525 shares of common stock..."
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
What did Harvard Bioscience (HBIO) director William Snider report on this Form 4?
William Snider reported receiving 16,556 restricted stock units of Harvard Bioscience common stock as a grant. These units are part of his director compensation and increase his total holdings, combining both stock awards and previously purchased shares.
How and when do William Snider’s new restricted stock units in HBIO vest?
The 16,556 restricted stock units vest in full either immediately before Harvard Bioscience’s next annual meeting or one year from the grant date, whichever happens first. Until vesting, the units represent a right to receive shares subject to service-based conditions.
What are William Snider’s total reported holdings in Harvard Bioscience after this transaction?
After the grant, Snider’s total reported holdings are 48,556 common share equivalents. This figure includes the new restricted stock units, common shares purchased on March 16 and March 17, 2026, and 11,000 restricted stock units vesting on December 17, 2026.
Was there a stock split affecting William Snider’s HBIO restricted stock units?
Yes. On March 13, 2026, Harvard Bioscience completed a 10-for-1 reverse stock split. As a result, 11,000 restricted stock units now reported were previously shown as 110,000 units, and the number was adjusted to reflect the split ratio.
What does the zero price on William Snider’s HBIO restricted stock unit grant indicate?
The $0.00 price indicates these 16,556 restricted stock units were granted as compensation, not purchased in the open market. Such awards typically vest over time and then convert into common shares without the director paying an exercise price.